Antiviral resistance in influenza viruses
Open Access
- 10 December 2023
- journal article
- research article
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 69 (13) , 16-23
Abstract
Influenza represents a major threat to public health worldwide, vaccination is the most effective strategy to reduce infections. However, achieving adequate vaccination rates is challenging and vaccination does not always guarantee complete protection. For this reason, antiviral drugs represent an important measure to reduce the risk of complications in high-risk patients. However, influenza viruses have a high mutation rate which causes genetic, biochemical, and pathogenic changes that represent a challenge both for the constant replacement of vaccines and reduce their susceptibility to antiviral action. This makes it necessary to determine the mechanisms of these processes, as well as their epidemiological surveillance and, of course, the development of new therapeutic options that may be available in the event of a widespread resistance phenomenon. In this article we review some of the relevant aspects of the replicative cycle of influenza viruses, the antivirals currently used, as well as their resistance mechanisms.Keywords
This publication has 41 references indexed in Scilit:
- 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and MononegaviralesArchives of Virology, 2020
- Peramivir: A Review in Uncomplicated InfluenzaDrugs, 2018
- Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017Antiviral Research, 2018
- Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016Antiviral Research, 2017
- Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015Antiviral Research, 2016
- Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistanceAntiviral Research, 2013
- Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivirAntiviral Research, 2007
- Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United StatesJAMA, 2006
- Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificityVirus Research, 1993
- Influenza virus M2 protein has ion channel activityCell, 1992